1. Home
  2. PHIO vs DOGZ Comparison

PHIO vs DOGZ Comparison

Compare PHIO & DOGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phio Pharmaceuticals Corp.

PHIO

Phio Pharmaceuticals Corp.

HOLD

Current Price

$0.65

Market Cap

10.1M

Sector

Health Care

ML Signal

HOLD

Logo Dogness (International) Corporation

DOGZ

Dogness (International) Corporation

HOLD

Current Price

$0.22

Market Cap

10.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHIO
DOGZ
Founded
2003
2003
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Miscellaneous manufacturing industries
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.1M
10.6M
IPO Year
2011
2017

Fundamental Metrics

Financial Performance
Metric
PHIO
DOGZ
Price
$0.65
$0.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
53.7K
★ 106.6K
Earning Date
11-05-2026
09-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.70
$0.25
52 Week High
$1.88
$13.00

Technical Indicators

Market Signals
Indicator
PHIO
DOGZ
Relative Strength Index (RSI) 27.10 8.53
Support Level N/A N/A
Resistance Level $1.12 $1.41
Average True Range (ATR) 0.07 0.07
MACD -0.01 -0.02
Stochastic Oscillator 5.14 0.05

Price Performance

Historical Comparison
PHIO
DOGZ

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762 and PH-894. The group is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. It is committed to discovering and developing cancer treatments for patients by creating new pathways toward a cancer-free future. The Company operates with a single operating segment, the Clinical segment, and all assets are located in the United States.

About DOGZ Dogness (International) Corporation

Dogness (International) Corp designs, manufactures pet products, including leashes and smart products, and lanyards. The company designs, processes, and manufactures fashionable and high-quality leashes, collars, and harnesses to complement cats and dogs appearances, as well as intelligent pet products. The company also provides dyeing services to external customers, as well as pet grooming services. The dyeing service is to utilize the existing production capacity and the pet grooming service is immaterial. Geographically, it generates maximum revenue from Europe and also has a presence in the Mainland China, United States, Europe, Australia, Canada, Central, and South America, Japan, and other Asian countries and regions.

Share on Social Networks: